These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23933078)

  • 1. Chimeric adenoviral vector Ad5F35L containing the Ad5 natural long-shaft exhibits efficient gene transfer into human T lymphocytes.
    Zhang WF; Wu FL; Shao HW; Wang T; Huang XT; Li WL; Shen H; Huang SL
    J Virol Methods; 2013 Dec; 194(1-2):52-9. PubMed ID: 23933078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors.
    Schroers R; Hildebrandt Y; Hasenkamp J; Glass B; Lieber A; Wulf G; Piesche M
    Exp Hematol; 2004 Jun; 32(6):536-46. PubMed ID: 15183894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
    Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT
    Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient gene transfer into normal human B lymphocytes with the chimeric adenoviral vector Ad5/F35.
    Jung D; Néron S; Drouin M; Jacques A
    J Immunol Methods; 2005 Sep; 304(1-2):78-87. PubMed ID: 16129448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector.
    Sakurai F; Mizuguchi H; Hayakawa T
    Gene Ther; 2003 Jun; 10(12):1041-8. PubMed ID: 12776162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
    Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T; Mizuguchi H
    Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
    Li D; Duan L; Freimuth P; O'Malley BW
    Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cells.
    Ulasov IV; Rivera AA; Han Y; Curiel DT; Zhu ZB; Lesniak MS
    J Neurosurg; 2007 Sep; 107(3):617-27. PubMed ID: 17886563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficiency of transduction of leukemic cells by fiber-modified adenoviruses.
    Yotnda P; Zompeta C; Heslop HE; Andreeff M; Brenner MK; Marini F
    Hum Gene Ther; 2004 Dec; 15(12):1229-42. PubMed ID: 15684699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fiber-modified adenovirus vectors containing the TAT peptide derived from HIV-1 in the fiber knob have efficient gene transfer activity.
    Kurachi S; Tashiro K; Sakurai F; Sakurai H; Kawabata K; Yayama K; Okamoto H; Nakagawa S; Mizuguchi H
    Gene Ther; 2007 Aug; 14(15):1160-5. PubMed ID: 17508008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient delivery and stable gene expression in a hematopoietic cell line using a chimeric serotype 35 fiber pseudotyped helper-dependent adenoviral vector.
    Balamotis MA; Huang K; Mitani K
    Virology; 2004 Jun; 324(1):229-37. PubMed ID: 15183069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication.
    Kawakami Y; Li H; Lam JT; Krasnykh V; Curiel DT; Blackwell JL
    Cancer Res; 2003 Mar; 63(6):1262-9. PubMed ID: 12649186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients.
    Brouwer E; Havenga MJ; Ophorst O; de Leeuw B; Gijsbers L; Gillissen G; Hoeben RC; ter Horst M; Nanda D; Dirven C; Avezaat CJ; Goudsmit J; Sillevis Smitt P
    Cancer Gene Ther; 2007 Feb; 14(2):211-9. PubMed ID: 17082793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells.
    Chen L; Chen D; Gong M; Na M; Li L; Wu H; Jiang L; Qian Y; Fang G; Xue X
    Cancer Lett; 2009 Nov; 284(2):141-8. PubMed ID: 19447545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
    Zheng S; Ulasov IV; Han Y; Tyler MA; Zhu ZB; Lesniak MS
    J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anionic liposomes increase the efficiency of adenovirus-mediated gene transfer to coxsackie-adenovirus receptor deficient cells.
    Zhong Z; Shi S; Han J; Zhang Z; Sun X
    Mol Pharm; 2010 Feb; 7(1):105-15. PubMed ID: 19968324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced neuroblastoma transduction for an improved antitumor vaccine.
    Davidoff AM; Stevenson SC; McClelland A; Shochat SJ; Vanin EF
    J Surg Res; 1999 May; 83(2):95-9. PubMed ID: 10329101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transduction and cell entry pathway of fiber-modified adenovirus type 5 vectors carrying novel endocytic peptide ligands selected on human tracheal glandular cells.
    Gaden F; Franqueville L; Magnusson MK; Hong SS; Merten MD; Lindholm L; Boulanger P
    J Virol; 2004 Jul; 78(13):7227-47. PubMed ID: 15194799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
    Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
    Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.
    Suleman M; Galea S; Gavard F; Merillon N; Klonjkowski B; Tartour E; Richardson J
    Vaccine; 2011 Aug; 29(35):5892-903. PubMed ID: 21723900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.